肌肉减少症的分子机制和发病机制：概述。
Molecular Mechanism and Pathogenesis of Sarcopenia: An Overview.
机构信息
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, 17165 Stockholm, Sweden.
出版信息
Int J Mol Sci. 2021 Mar 16;22(6):3032. doi: 10.3390/ijms22063032.
Abstract
Sarcopenia involves a progressive age-related decline of skeletal muscle mass and strength/function [...].
摘要
肌肉减少症涉及骨骼肌质量和力量/功能的进行性与年龄相关的下降[... ]。
相似文献
1
Molecular Mechanism and Pathogenesis of Sarcopenia: An Overview.肌肉减少症的分子机制和发病机制：概述。
Int J Mol Sci. 2021 Mar 16;22(6):3032. doi: 10.3390/ijms22063032.
2
Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis.炎症性衰老作为肌肉减少症、肥胖症、心肌病和肠道菌群失调发展和维持的共同基础。
Ageing Res Rev. 2019 Dec;56:100980. doi: 10.1016/j.arr.2019.100980. Epub 2019 Nov 11.
3
Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis.肌少症性肥胖或肥胖性肌少症：与年龄相关的脂肪组织和骨骼肌炎症之间的串扰是发病机制的主要机制。
Ageing Res Rev. 2017 May;35:200-221. doi: 10.1016/j.arr.2016.09.008. Epub 2016 Oct 1.
4
Extracellular matrix/mitochondria pathway: A novel potential target for sarcopenia.细胞外基质/线粒体途径：肌少症的一个新的潜在靶点。
Mitochondrion. 2020 Jan;50:63-70. doi: 10.1016/j.mito.2019.10.007. Epub 2019 Oct 24.
5
The NLRP3 inflammasome contributes to sarcopenia and lower muscle glycolytic potential in old mice.NLRP3炎性小体导致老年小鼠肌肉减少症和较低的肌肉糖酵解能力。
Am J Physiol Endocrinol Metab. 2017 Aug 1;313(2):E222-E232. doi: 10.1152/ajpendo.00060.2017. Epub 2017 May 23.
6
The Association between Parameters of Malnutrition and Diagnostic Measures of Sarcopenia in Geriatric Outpatients.老年门诊患者营养不良参数与肌肉减少症诊断指标之间的关联
PLoS One. 2015 Aug 18;10(8):e0135933. doi: 10.1371/journal.pone.0135933. eCollection 2015.
7
Contribution of uremic dysbiosis to insulin resistance and sarcopenia.尿毒症性菌群失调对胰岛素抵抗和肌肉减少症的影响。
Nephrol Dial Transplant. 2020 Sep 1;35(9):1501-1517. doi: 10.1093/ndt/gfaa076.
8
Mitochondrial morphology is altered in atrophied skeletal muscle of aged mice.老年小鼠萎缩骨骼肌中的线粒体形态发生改变。
Oncotarget. 2015 Jul 20;6(20):17923-37. doi: 10.18632/oncotarget.4235.
9
Taurine Attenuates Catabolic Processes Related to the Onset of Sarcopenia.牛磺酸可减弱与肌肉减少症发病相关的分解代谢过程。
Int J Mol Sci. 2020 Nov 23;21(22):8865. doi: 10.3390/ijms21228865.
10
The Interplay between Mitochondrial Morphology and Myomitokines in Aging Sarcopenia.线粒体形态与肌因子在衰老性肌肉减少症中的相互作用。
Int J Mol Sci. 2020 Dec 23;22(1):91. doi: 10.3390/ijms22010091.
引用本文的文献
1
The association of HALP score with low muscle mass in older adults.老年人中HALP评分与低肌肉量的关联。
Front Nutr. 2025 Aug 19;12:1618736. doi: 10.3389/fnut.2025.1618736. eCollection 2025.
2
Association between sarcopenia and falls, fractures, hospital readmission, and all-cause mortality in older adults with endocrine disorders: a longitudinal study of aging in China.内分泌疾病老年患者中肌肉减少症与跌倒、骨折、再入院及全因死亡率的关联：中国老龄化纵向研究
BMC Musculoskelet Disord. 2025 Sep 2;26(1):842. doi: 10.1186/s12891-025-09117-6.
3
The impact of sarcopenia on the efficacy of posterior surgical treatment for degenerative lumbar scoliosis.肌肉减少症对退变性腰椎侧凸后路手术治疗疗效的影响。
BMC Surg. 2025 Aug 14;25(1):372. doi: 10.1186/s12893-025-03075-5.
4
Exploring the role of traditional Chinese medicine in sarcopenia: mechanisms and therapeutic advances.探索中医在肌肉减少症中的作用：机制与治疗进展
Front Pharmacol. 2025 Jun 30;16:1541373. doi: 10.3389/fphar.2025.1541373. eCollection 2025.
5
Association between body folate status and muscle mass: a cross-sectional study of the National Health and Nutrition Examination Survey 2011-2018.机体叶酸状态与肌肉量之间的关联：一项基于2011 - 2018年美国国家健康与营养检查调查的横断面研究
J Health Popul Nutr. 2025 Jul 12;44(1):250. doi: 10.1186/s41043-025-01005-y.
6
Lactoferrin combined with Coenzyme Q10 ameliorate sarcopenia in an aging mouse model induced by D-galactose.乳铁蛋白联合辅酶Q10改善D-半乳糖诱导的衰老小鼠模型中的肌肉减少症。
PLoS One. 2025 Jun 26;20(6):e0325297. doi: 10.1371/journal.pone.0325297. eCollection 2025.
7
Targeting ryanodine receptors with allopurinol and xanthine derivatives for the treatment of cardiac and musculoskeletal weakness disorders.用别嘌呤醇和黄嘌呤衍生物靶向兰尼碱受体治疗心脏和肌肉骨骼无力症。
Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2422082122. doi: 10.1073/pnas.2422082122. Epub 2025 Jun 13.
8
Global research trends in sarcopenia: a bibliometric analysis of exercise and nutrition (2005-2025).肌肉减少症的全球研究趋势：运动与营养的文献计量分析（2005 - 2025年）
Front Nutr. 2025 May 16;12:1579572. doi: 10.3389/fnut.2025.1579572. eCollection 2025.
9
Unveiling the Anti-Aging Potential of Marine Natural Bioproducts.揭示海洋天然生物制品的抗衰潜力。
Mar Drugs. 2025 Apr 11;23(4):165. doi: 10.3390/md23040165.
10
Molecular and Cellular Mechanisms Linking Chronic Kidney Disease and Sarcopenia in Aging: An Integrated Perspective.衰老过程中慢性肾脏病与肌肉减少症关联的分子和细胞机制：综合视角
Clin Interv Aging. 2025 Apr 8;20:449-458. doi: 10.2147/CIA.S516704. eCollection 2025.
本文引用的文献
1
Cancer-Associated Muscle Wasting-Candidate Mechanisms and Molecular Pathways.癌症相关的肌肉萎缩——候选机制和分子途径
Int J Mol Sci. 2020 Dec 4;21(23):9268. doi: 10.3390/ijms21239268.
2
Sarcopenia: Molecular Pathways and Potential Targets for Intervention.肌肉减少症：干预的分子途径和潜在靶点。
Int J Mol Sci. 2020 Nov 22;21(22):8844. doi: 10.3390/ijms21228844.
3
Exercise and the Cisd2 Prolongevity Gene: Two Promising Strategies to Delay the Aging of Skeletal Muscle.运动与 CisD2 长寿基因：延缓骨骼肌衰老的两种有前途的策略。
Int J Mol Sci. 2020 Nov 28;21(23):9059. doi: 10.3390/ijms21239059.
4
The Gut-Muscle Axis in Older Subjects with Low Muscle Mass and Performance: A Proof of Concept Study Exploring Fecal Microbiota Composition and Function with Shotgun Metagenomics Sequencing.低肌肉量和身体机能老年人的“肠-肌肉轴”：一项利用宏基因组测序技术探索粪便微生物群落组成和功能的概念验证研究。
Int J Mol Sci. 2020 Nov 25;21(23):8946. doi: 10.3390/ijms21238946.
5
Impact of Mitophagy and Mitochondrial Unfolded Protein Response as New Adaptive Mechanisms Underlying Old Pathologies: Sarcopenia and Non-Alcoholic Fatty Liver Disease.作为潜在旧病理学（如肌肉减少症和非酒精性脂肪性肝病）新适应机制的自噬和线粒体未折叠蛋白反应的影响。
Int J Mol Sci. 2020 Oct 18;21(20):7704. doi: 10.3390/ijms21207704.
6
Circulating Mitochondrial-Derived Vesicles, Inflammatory Biomarkers and Amino Acids in Older Adults With Physical Frailty and Sarcopenia: A Preliminary BIOSPHERE Multi-Marker Study Using Sequential and Orthogonalized Covariance Selection - Linear Discriminant Analysis.身体虚弱和肌肉减少症的老年人循环线粒体衍生囊泡、炎症生物标志物和氨基酸：一项使用顺序和正交协方差选择-线性判别分析的初步生物圈多标记物研究
Front Cell Dev Biol. 2020 Sep 22;8:564417. doi: 10.3389/fcell.2020.564417. eCollection 2020.
7
Muscle Wasting and Sarcopenia in Heart Failure-The Current State of Science.心力衰竭中的肌肉减少症和肌少症——科学的现状。
Int J Mol Sci. 2020 Sep 8;21(18):6549. doi: 10.3390/ijms21186549.
8
Sarcopenia in Autoimmune and Rheumatic Diseases: A Comprehensive Review.自身免疫和风湿性疾病相关的肌肉减少症：全面综述。
Int J Mol Sci. 2020 Aug 7;21(16):5678. doi: 10.3390/ijms21165678.
9
Biomarkers of Physical Frailty and Sarcopenia: Coming up to the Place?身体虚弱和肌少症的生物标志物：即将到来？
Int J Mol Sci. 2020 Aug 6;21(16):5635. doi: 10.3390/ijms21165635.
10
Role of Age-Related Mitochondrial Dysfunction in Sarcopenia.衰老相关的线粒体功能障碍在肌肉减少症中的作用。
Int J Mol Sci. 2020 Jul 23;21(15):5236. doi: 10.3390/ijms21155236.
Zotero 插件